PharmatrophiX gets $300K for Alzheimer’s disease prevention drugs
See our story about this San Francisco biotech in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Bay Area regulators consider tax on greenhouse gas emissions
Previous Story: Sequans raises $28M for WiMAX chips
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.